Odyssey Therapeutics
Transforming the standard of care
Boston, United States · Founded 2021 · $700.0M raised
- Headquarters
- Boston, Massachusetts
- Employees
- 51–200
- Founded
- 2021
- Business Model
- B2B
- Website
- odysseytx.com
- Total Funding
- $700.0M
- Last Round
- $213.0M Series DSep 2025
- Rounds
- 4
About
Odyssey Therapeutics is a clinical-stage biopharmaceutical company developing next-generation small molecule and protein therapeutics for autoimmune and inflammatory diseases. Founded in 2021 and based in Boston, Odyssey uses a replicable and scalable drug discovery model combining AI-driven small molecule design with precision targeting of the innate immune system. The company has raised over $400 million across multiple financing rounds including a $213 million Series D in 2025.
Summary
Odyssey Therapeutics is a Biotech company based in Boston, United States, founded in 2021. It has raised $700.0M in total across 4 rounds, most recently a $213.0M Series D round in Sep 2025. Investors include SR One, Ascenta Capital and Lightspeed VP.
Tech & App Stack
6 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Sep 2025
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...